Switch to:
More From Other Websites
3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter May 22 2017
Valeant Pharmaceuticals: Intrigued…Really? May 19 2017
Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA May 19 2017
Allergan's Irritable Bowel Drug Viberzi Approved in Canada May 17 2017
Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss May 17 2017
Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan May 17 2017
Is Editas Facing a New Reality in CRISPR Land? May 16 2017
Cramer: Carl Icahn Was Right to Sell Apple at $95 May 16 2017
Biotech Movers: Akebia, Editas, Novavax May 16 2017
Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the... May 16 2017
VIBERZI™ Now Approved in Canada for patients with irritable bowel syndrome with diarrhea (IBS-D) May 16 2017
Several top fund managers trim Allergan stakes in first quarter May 15 2017
John Paulson Takes A Shine To Telecom May 15 2017
ETFs with exposure to Allergan Plc : May 15, 2017 May 15 2017
13-F Reveals Tepper's Big Bet on Bank of America May 15 2017
Allergan to Present at the Bernstein Strategic Decisions Conference May 15 2017
Still an Allergan Fan; Oil Vey!: Doug Kass' Views May 15 2017
Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT May 14 2017
Earnings Are Still Calling the Tune: Cramer's 'Mad Money' Recap (Friday 5/12/17) May 12 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK